Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Moffitt Cancer Center, Tampa, Florida

Winship Cancer Institute at Emory, Atlanta, Georgia

Mayo Clinic Rochester, Rochester, Minnesota

MD Anderson Cancer Center, Houston, Texas